Prováděcí rozhodnutí Komise (EU) 2026/924 ze dne 24. dubna 2026, kterým se mění příloha II prováděcího rozhodnutí (EU) 2025/2248 o některých mimořádných opatřeních v souvislosti s infekcí virem nodulární dermatitidy skotu ve Španělsku (oznámeno pod číslem C(2026)2811)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (Animal Health Law)OJ L 84, 31.3.2016, p. 1 , ELI: http://data.europa.eu/eli/reg/2016/429/oj. , and in particular Article 259(1) thereof,

The Annex II to Implementing Decision (EU) 2025/2248 is replaced by the text set out in the Annex to this Decision.

OJ L 84, 31.3.2016, p. 1 , ELI: http://data.europa.eu/eli/reg/2016/429/oj.

(1) Infection with lumpy skin disease virus is an infectious, vector-borne disease affecting bovine animals. Its occurrence can have a severe impact on the concerned animal population and on the profitability of farming, also causing disturbance to movements of consignments of those animals and products thereof within the Union and exports to third countries. In the event of an outbreak of infection with lumpy skin disease virus in bovine animals, there is a serious risk of the spread of that disease to other establishments keeping bovine animals, particularly due to its mode of transmission through vectors.

(2) Commission Delegated Regulation (EU) 2020/687Commission Delegated Regulation (EU) 2020/687 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council, as regards rules for the prevention and control of certain listed diseases (OJ L 174, 3.6.2020, p. 64 , ELI: http://data.europa.eu/eli/reg_del/2020/687/oj). supplements the rules for the control of the listed diseases referred to in Article 9(1), points (a), (b) and (c), of Regulation (EU) 2016/429, and defined as category A, B and C diseases in Commission Implementing Regulation (EU) 2018/1882Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and control rules to categories of listed diseases and establishing a list of species and groups of species posing a considerable risk for the spread of those listed diseases (OJ L 308, 4.12.2018, p. 21 , ELI: http://data.europa.eu/eli/reg_impl/2018/1882/oj). . In particular, Articles 21 and 22 of Delegated Regulation (EU) 2020/687 provide for the establishment of a restricted zone in the event of an outbreak of a category A disease, including infection with lumpy skin disease virus, and for certain measures to be applied therein. In addition, Article 21(1) of that Delegated Regulation provides that the restricted zone is to comprise at least a protection zone, a surveillance zone, and, if necessary, further restricted zones around or adjacent to the protection and surveillance zones.

(3) The size of the protection and surveillance zones, and the duration of the measures to be applied therein, are based on the criteria laid down in Article 64(1) of Regulation (EU) 2016/429, as well as on the rules laid down in Delegated Regulation (EU) 2020/687. The criteria applied for the choice of the size of the protection and surveillance zones, as well as of the duration of the measures to be applied therein, include a consideration of not only the epidemiological situation as regards infection with lumpy skin disease virus in the areas affected by that disease, but also of other epidemiological factors, including geographical parameters and the risk for the further spread of the disease. The chosen duration of the measures provided for in this Decision has also taken into account the international standards of the Terrestrial Animal Health Code of the World Organisation for Animal Healthhttps://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/. .

(4) Regulation (EU) 2016/429, and in particular Article 69 thereof, provides that the competent authority of a Member State may use emergency vaccination for the effective control of a listed disease, as referred to in Article 9(1), point (a), of that Regulation, in kept animals. To that end, the competent authority may establish vaccination zones and develop a vaccination plan that meets specific requirements. Commission Delegated Regulation (EU) 2023/361Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (OJ L 52, 20.2.2023, p. 1 , ELI: http://data.europa.eu/eli/reg_del/2023/361/oj). , which supplements the rules laid down in Regulation (EU) 2016/429, lays down, inter alia, the specific rules to be implemented by Member States when using emergency protective vaccination in bovine animals to prevent or control certain listed diseases. That Delegated Regulation also lays down the conditions under which the movements of vaccinated animals and products thereof may be allowed. Specific conditions for emergency protective vaccination against infection with lumpy skin disease virus are laid down in Annex IX to that Delegated Regulation.

(5) Commission Implementing Decision (EU) 2025/2248Commission Implementing Decision (EU) 2025/2248 of 4 November 2025 concerning certain emergency measures relating to infection with lumpy skin disease virus in Spain and repealing Implementing Decision (EU) 2025/2076 (OJ L, 2025/2248, 7.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2248/oj). lays down certain emergency measures relating to infection with lumpy skin disease virus in Spain. More particularly, Article 1, point (a), of that Implementing Decision requires the establishment of a restricted zone, comprising protection and surveillance zones, in accordance with Article 21 of Delegated Regulation (EU) 2020/687, in that Member State, which must comprise at least the areas listed in Annex I to that Implementing Decision. In addition, Article 1, point (b), of that Implementing Decision provides for the establishment in Spain of vaccination zones I and II, in accordance with Part I of Annex IX to Delegated Regulation (EU) 2023/361, and under the conditions laid down therein. It also provides that those vaccination zones must comprise at least the areas listed as such in Annex II to Implementing Decision (EU) 2025/2248. Furthermore, Article 1, point (c), of Implementing Decision (EU) 2025/2248 provides that the measures required to be applied in the protection and surveillance zones, as well as in vaccination zones I and II, are to apply at least until the dates listed in the Annexes to that Implementing Decision.

(6) Following the most recent amendment of Implementing Decision (EU) 2025/2248 by Commission Implementing Decision (EU) 2026/852Commission Implementing Decision (EU) 2026/852 of 10 April 2026 amending Annex II to Implementing Decision (EU) 2025/2248 concerning certain emergency measures relating to infection with lumpy skin disease virus in Spain (OJ L, 2026/852, 15.4.2026, ELI: http://data.europa.eu/eli/dec_impl/2026/852/oj). , on 6 April 2026 , Spain notified the Commission of a technical error in the description of certain municipalities listed in Annex II to Implementing Decision (EU) 2025/2248, in particular concerning territories in Catalonia and the Basque Country.

(7) In order to correct that technical error and ensure the accurate description of the vaccination zones, the areas listed for vaccination zones I and II in Parts A and B of Annex II to Implementing Decision (EU) 2025/2248 should be amended accordingly.

(8) In light of the current epidemiological situation in Spain, and in order to ensure legal clarity and the proper implementation of disease control measures, the amendments to Implementing Decision (EU) 2025/2248 provided for in this Decision should apply as soon as possible. This is necessary to prevent the further spread of the disease within Spain, to other Member States and to third countries, and to avoid unnecessary disturbances to trade within the Union or unjustified barriers to trade with third countries.

(9) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

This Decision is addressed to the Kingdom of Spain.

Commission Delegated Regulation (EU) 2020/687 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council, as regards rules for the prevention and control of certain listed diseases (OJ L 174, 3.6.2020, p. 64 , ELI: http://data.europa.eu/eli/reg_del/2020/687/oj).

Article 1 Article 1

Article 2 Article 2

Commission Implementing Regulation (EU) 2018/1882 of 3 December 2018 on the application of certain disease prevention and control rules to categories of listed diseases and establishing a list of species and groups of species posing a considerable risk for the spread of those listed diseases (OJ L 308, 4.12.2018, p. 21 , ELI: http://data.europa.eu/eli/reg_impl/2018/1882/oj).

https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/.

Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (OJ L 52, 20.2.2023, p. 1 , ELI: http://data.europa.eu/eli/reg_del/2023/361/oj).

Commission Implementing Decision (EU) 2025/2248 of 4 November 2025 concerning certain emergency measures relating to infection with lumpy skin disease virus in Spain and repealing Implementing Decision (EU) 2025/2076 (OJ L, 2025/2248, 7.11.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/2248/oj).

Commission Implementing Decision (EU) 2026/852 of 10 April 2026 amending Annex II to Implementing Decision (EU) 2025/2248 concerning certain emergency measures relating to infection with lumpy skin disease virus in Spain (OJ L, 2026/852, 15.4.2026, ELI: http://data.europa.eu/eli/dec_impl/2026/852/oj).

HAS ADOPTED THIS DECISION: